3-iodobenzylguanidine has been researched along with Heart Failure in 290 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 37 (12.76) | 18.2507 |
| 2000's | 73 (25.17) | 29.6817 |
| 2010's | 143 (49.31) | 24.3611 |
| 2020's | 37 (12.76) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunami, M; Furukawa, Y; Kawahira, M; Kawai, T; Kawasaki, M; Kayama, K; Kikuchi, A; Kimura, T; Morita, T; Nakamura, J; Sakamoto, D; Sakata, Y; Seo, M; Tamaki, S; Ueda, K; Watanabe, T; Yamada, T | 1 |
| Fujita, T; Fukuda, Y; Fukunami, M; Kawai, T; Kawasaki, M; Kayama, K; Kikuchi, A; Kogame, T; Kokubu, Y; Morita, T; Nakamura, J; Nishigaki, K; Sakamoto, D; Seo, M; Tamaki, S; Tamura, Y; Ueda, K; Watanabe, T; Yamada, T | 1 |
| Travin, MI | 6 |
| Abbate, V; Acampa, W; Asile, G; Assante, R; Basile, C; Cuocolo, A; Dellegrottaglie, S; Gargiulo, P; Marzano, F; Nappi, C; Nardi, E; Paolillo, S; Parlati, ALM; Perrone-Filardi, P | 1 |
| Higuchi, T; Rowe, SP; Serfling, SE; Werner, RA | 1 |
| Assante, R; Bencivenga, L; Corbi, GM; Cuocolo, A; Femminella, GD; Ferrara, N; Gambino, G; Gargiulo, P; Komici, K; Nappi, C; Paolillo, S; Perrone-Filardi, P; Rengo, G; Santillo, F | 1 |
| Agostini, D; Ananthasubramaniam, K; Chandna, H; Chen, K; Dahl, JV; Friberg, L; Hudnut, A; Koren, M; Levy, WC; Miyamoto, MI; Senior, R; Shah, M; Travin, MI | 1 |
| Verberne, HJ; Verschure, DO | 1 |
| Gimelli, A; Liga, R | 1 |
| Farcomeni, A; Frantellizzi, V; Pani, A; Pontico, M; Ricci, M; Vincentis, G | 1 |
| Abe, M; Fukunami, M; Furukawa, Y; Kawahira, M; Kawai, T; Kawasaki, M; Kayama, K; Kikuchi, A; Kimura, T; Morita, T; Nakamura, J; Sakamoto, D; Sakata, Y; Seo, M; Tamaki, S; Tanabe, K; Ueda, K; Watanabe, T; Yamada, T; Yamamoto, K | 1 |
| Abe, M; Fujita, T; Fukunami, M; Furukawa, Y; Kawahira, M; Kawai, T; Kawasaki, M; Kayama, K; Kikuchi, A; Kimura, T; Morita, T; Nakamura, J; Sakamoto, D; Seo, M; Tamaki, S; Tamura, Y; Tanabe, K; Ueda, K; Yamada, T; Yamamoto, K | 1 |
| de Groot, JR; De Vincentis, G; Frantellizzi, V; Gheysens, O; Nakajima, K; Poel, E; Verberne, HJ; Verschure, DO | 1 |
| Furusho, H; Hamaoka, T; Kaneko, S; Kato, T; Matsuo, S; Mukai, Y; Murai, H; Okabe, Y; Sugimoto, H; Takamura, M; Takashima, SI; Tokuhisa, H; Usui, S | 1 |
| Gulya, MO; Lebedev, DI; Lishmanov, YB; Mishkina, AI; Popov, SV; Varlamova, YV; Zavadovsky, KV | 1 |
| Doi, T; Maruyama, K; Nakajima, K; Nakata, T; Tada, H | 1 |
| Jacobson, AF; Matsuoka, DT | 1 |
| Atabekov, TA; Batalov, RE; Mishkina, AI; Popov, SV; Sazonova, SI; Varlamova, JV; Zavadovsky, KV | 1 |
| Fukunami, M; Furukawa, Y; Kawahira, M; Kawai, T; Kawasaki, M; Kayama, K; Kikuchi, A; Morita, T; Nakamura, J; Seo, M; Tamaki, S; Watanabe, T; Yamada, T | 1 |
| Brunotti, G; Conte, M; Corica, F; Cosma, L; De Angelis, C; De Feo, MS; De Vincentis, G; Di Rocco, A; Farcomeni, A; Frantellizzi, V; Lazri, J; Matto, A; Montebello, M; Pontico, M | 1 |
| Assante, R; Bencivenga, L; Cittadini, A; Cuocolo, A; Femminella, GD; Ferrara, N; Filardi, PP; Formisano, R; Gargiulo, P; Komici, K; Nappi, C; Paolillo, S; Puzone, B; Rengo, G; Sepe, I; Vitale, DF | 1 |
| Fukuda, K; Hasegawa, S; Higashimori, A; Hirata, K; Kawamura, T; Waratani, N; Yokoi, Y | 1 |
| Abe, H; Dohi, T; Fuji, H; Higuchi, Y; Hikoso, S; Kida, H; Kitamura, T; Kojima, T; Kurakami, H; Mano, T; Mizuno, H; Nakagawa, Y; Nakatani, D; Oeun, B; Okada, K; Sakata, Y; Sato, T; Sotomi, Y; Suna, S; Sunaga, A; Uematsu, M; Yamada, T; Yasumura, Y | 1 |
| Bandyopadhyay, D; Gerard, P; Jain, D | 1 |
| Marcassa, C | 2 |
| Angeli, F; Barbieri, M; Bergamaschi, L; Casella, G; Fabrizio, M; Foà, A; Galiè, N; Gatta, G; Marfella, R; Paolisso, P; Pizzi, C; Rambaldi, P; Sardu, C | 1 |
| Henzlova, MJ; Jacobson, AF; Jain, D; Poel, E; Travin, MI; Verberne, HJ; Verschure, DO | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda, I; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Nakamura, J; Ozaki, T; Sato, Y; Seo, M; Tamaki, S; Yamada, T; Yamamoto, H | 1 |
| Liga, R; Scholte, AJHA | 1 |
| Bax, JJ | 1 |
| Ambrosio, G; Cameli, M; Cerbai, E; Coiro, S; Emdin, M; Gimelli, A; Liga, R; Marcucci, R; Marzullo, P; Morrone, D; Padeletti, L; Palazzuoli, A; Pedrinelli, R; Petronio, AS; Savino, K | 1 |
| Doi, T; Fukahara, K; Fukuda, N; Ito, H; Kinugawa, K; Kuwahara, H; Nagura, S; Onoda, H; Sobajima, M; Tanaka, S; Ueno, H; Ushijima, R; Yamashita, A; Yokoyama, S | 1 |
| Abreu, A; Carmo, MM; Cruz, MC; Cunha, PS; Ferreira, RC; Morais, LA; Oliveira, L; Oliveira, MM; Portugal, G; Rio, P; Rodrigues, I; Santa-Clara, H; Santos, V | 1 |
| Doi, T; Jacobson, AF; Kadokami, T; Konno, T; Matsuo, S; Nakajima, K; Nakata, T; Yamada, T | 1 |
| Jain, D | 1 |
| De Vincentis, G; Farcomeni, A; Fedele, F; Fegatelli, DA; Frantellizzi, V; Mancone, M; Salvi, N; Scarparo, P; Verberne, HJ; Verschure, DO | 1 |
| Teresińska, A | 1 |
| Abreu, A; Carmo, MM; Clara, HS; Cruz, MC; Cunha, PS; Ferreira, RC; Moreira, RI; Oliveira, L; Oliveira, M; Portugal, G; Rodrigues, I; Santos, V | 1 |
| Doytchinova, A; Gerson, MC | 1 |
| Braga, DS; Dumont, SM; Freitas, SS; Marino, VSP; Moreira, MDCV; Mota, LDG | 1 |
| Matsunari, I; Nakajima, K; Thomas, GS; Travin, MI; Yoshinaga, K | 1 |
| Werner, RA | 1 |
| Alfonso, G; Claudio, M; Giacomo, C; Giovanni, B; Giovanni, S; Margherita, C; Paola, P; Pierfranco, D; Riccardo, C; Stefano, M; Teresa, SM; Umberto, P | 1 |
| Hashimoto, H; Hashimoto, Y; Ikeda, T; Mizumura, S; Nakanishi, R; Okamura, Y; Yamanaka, K; Yamazaki, J | 1 |
| AlJaroudi, W | 1 |
| Ito, Y; Kasahara, M; Kasama, S; Kurabayashi, M; Matsumoto, N; Suzuki, S; Toyama, T | 1 |
| Currie, G; Iqbal, B; Kiat, H | 1 |
| Citro, R; D'Auria, F; Galasso, G; Pace, L; Piscione, F; Polito, MV; Scarano, M; Silverio, A; Vitulano, G | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda-Yorifuji, I; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Morita, T; Nakamura, J; Seo, M; Tamaki, S; Yamada, T | 1 |
| Iwanaga, Y; Matsuura, T; Miyazaki, S; Ueno, M | 1 |
| Ideguchi, T; Ishikawa, T; Kitamura, K; Koyama, S; Nagamachi, S; Onitsuka, H | 1 |
| Pamboukian, SV; Rajapreyar, I | 1 |
| Carnagarin, R; Chan, JJS; Dwivedi, G; Ho, JK; Kiuchi, MG; Lugo-Gavidia, LM; Matthews, VB; Nolde, JM; Schlaich, MP; Villacorta, H | 1 |
| Iwahana, T; Kitahara, H; Kobayashi, Y; Miyauchi, H; Okada, S; Sugiura, A; Suzuki, N; Werner, N | 1 |
| Arai-Okuda, H; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tani, R; Yamamoto, Y | 1 |
| Ahmadi, A; Beanlands, RS; deKemp, RA; Mielniczuk, LM; Nair, GM; Narula, J; Rotstein, BH; Zelt, JGE | 1 |
| Fukunami, M; Furukawa, Y; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Morita, T; Sakata, Y; Seo, M; Tamaki, S; Yamada, T | 1 |
| Attena, E; Boemio, A; Cuocolo, A; Femminella, GD; Formisano, R; Galasso, G; Leosco, D; Pagano, G; Paolillo, S; Pellegrino, T; Perrone-Filardi, P; Petraglia, L; Rengo, G; Savarese, G; Scopacasa, F; Trimarco, B; Tuccillo, M | 1 |
| Azevedo, JC; Benayon, PC; Carreira, MA; Maróstica, E; Mesquita, CT; Mesquita, ET; Messias, LR; Miranda, SM; Rodrigues, RC | 1 |
| Abdallah, M; Dwivedi, AK; Gerson, MC; Jacobson, AF; Shukla, R | 1 |
| Abe, K; Baba, S; Higo, T; Honda, H; Isoda, T; Jinnouchi, M; Kamitani, T; Maruoka, Y; Matsuo, Y; Nagao, M; Yamasaki, Y; Yonezawa, M; Yoshiura, T | 1 |
| Martins da Silva, MI; Morão Moreira, AP; Vidigal Ferreira, MJ | 1 |
| Boemio, A; Carotenuto, R; Cuocolo, A; De Luca, S; di Nuzzo, C; Paolillo, S; Pellegrino, T; Perrone-Filardi, P; Petretta, M; Petretta, MP | 1 |
| Clements, IP; Hodge, DO; Jacobson, AF; Wiseman, GA | 1 |
| Jacobson, AF; Kasama, S; Matsui, T; Matsuo, S; Momose, M; Nakajima, K; Nakata, T; Travin, MI; Yamada, T; Yamashina, S | 2 |
| Bakx, A; de Peuter, OR; Kamphuisen, PW; Kok, WE; Meijers, JC; Nieuwland, R; Schaap, MC; Somsen, GA; van den Bogaard, B; Verberne, HJ | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
| Hashimoto, A; Nakata, T; Sugawara, H | 1 |
| Christensen, TE; Hasbak, P; Kjaer, A | 1 |
| Bunker, CH; Malhotra, S; Soman, P; Wang, L; Winger, D | 1 |
| Agostini, D; Belin, A; Besson, FL; Coutance, G; Manrique, A | 1 |
| Friedman, NC; Grady, E; Hassan, A; Jacobson, AF; Matsuoka, DT | 1 |
| Bongers, V; Hagen, PJ; Somsen, GA; van Eck-Smit, BL; Verberne, HJ; Verschure, DO | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Nakata, T; Sumino, H; Toyama, T | 1 |
| Agostini, D; Gerson, MC; Jacobson, AF; Katsikis, A; Koutelou, M; Manrique, A; Scholte, AJ; Somsen, GA; van Eck-Smit, BL; Veltman, CE; Verberne, HJ; Verschure, DO | 1 |
| Abe, Y; Asano, Y; Iizuka, T; Inoue, Y; Kikuchi, K; Matsunaga, K; Nishiyama, K | 1 |
| Fujisaki, H; Fukuchi, K; Ishida, Y; Katafuchi, T; Kiso, K; Murase, K; Nishimura, Y | 1 |
| Ahlberg, AW; Heller, GV; Jacobson, AF; Lundbye, JB; Parker, MW; Sood, N | 1 |
| Cuocolo, A; Pellegrino, T; Petretta, M | 1 |
| Al Badarin, FJ; Bateman, TM; Jacobson, AF; Kennedy, KF; Wimmer, AP | 1 |
| Aban, I; Saba, S; Soman, P | 1 |
| Amanullah, A; Gupta, S | 1 |
| da Nóbrega, AC; Fernandes, IA; Freitas, RA; Mesquita, CT; Mesquita, ET; Miranda, SM; Vianna, LC | 1 |
| Hasbak, P; Kjær, A | 1 |
| Bongers, V; D'Aron, J; de Wit, TC; Hagen, PJ; Huber, K; Knoll, P; Mirzaei, S; Somsen, GA; Sonneck-Koenne, C; van Eck-Smit, BL; Verberne, HJ; Verschure, DO | 1 |
| Kasama, S; Kurabayashi, M; Toyama, T | 2 |
| de Azevedo, JC; Mesquita, CT; Mesquita, ET; Messias, LR; Miranda, SM; Moscavitch, SD; Pereira, SB; Ribeiro, GS; Rodrigues, RC | 1 |
| Fujimoto, S; Ichikawa, S; Kasama, S; Koitabashi, N; Kurabayashi, M; Matsumoto, N; Sano, H; Sato, Y; Suzuki, Y; Takama, N; Toyama, T | 1 |
| Butler, J; Chen, J; Clements, IP; Folks, RD; Garcia, EV; Jacobson, AF | 1 |
| Attena, E; Carotenuto, R; Cuocolo, A; Del Guercio, L; Formisano, R; Gargiulo, P; Leosco, D; Pagano, G; Paolillo, S; Pellegrino, T; Perrino, C; Perrone-Filardi, P; Petraglia, L; Piscitelli, S; Rapacciuolo, A; Rengo, G; Savarese, G; Trimarco, B | 1 |
| Fukunami, M; Furukawa, Y; Hakui, H; Ishimi, M; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Ozaki, T; Sakata, Y; Sato, Y; Seo, M; Takahashi, S; Tamaki, S; Yamada, T | 1 |
| Bevilacqua, A; Cuocolo, A; de Lucia, C; Femminella, GD; Ferrara, N; Ferro, G; Filardi, PP; Formisano, R; Leosco, D; Pagano, G; Paolillo, S; Parisi, V; Pellegrino, T; Prastaro, M; Rengo, G | 1 |
| Bertagna, F; Bertoli, M; Camoni, L; Campini, R; Fracassi, F; Giubbini, R; Marcassa, C; Milan, E; Motta, F; Paghera, B; Rodella, C | 1 |
| Jacobson, AF; Travin, MI | 1 |
| Nakajima, K; Nakata, T | 1 |
| Dilsizian, V; Narula, J | 1 |
| Udelson, JE; Wessler, BS | 1 |
| Dimitriu-Leen, AC; Jacobson, AF; Scholte, AJ | 1 |
| Borgquist, R; Singh, JP | 1 |
| Dilsizian, V; Eckelman, WC | 1 |
| Cerqueira, MD; Gerson, M; Jacobson, AF; Narula, J; Thomas, GS | 1 |
| Imamura, T; Kinoshita, O; Kinugawa, K; Nawata, K; Nitta, D; Ono, M | 1 |
| Agostini, D; Baavour, R; Bailliez, A; Bellevre, D; Blaire, T; Bross, S; Desmonts, C; Legallois, D; Manrique, A; Roth, N | 1 |
| Cerqueira, M; Farnum, C; Gold, M; Hendel, R; Narula, J; Shaw, L; Singh, J; Thomas, G; Wazni, O; Wolinsky, D | 1 |
| Al Younis, I; Bax, JJ; Dimitriu-Leen, AC; Gimelli, A; Scholte, AJHA; Veltman, CE; Verberne, HJ; Wolterbeek, R; Zandbergen-Harlaar, S | 1 |
| Butler, J; Chen, J; Clements, IP; Folks, R; Garcia, EV; Jacobson, AF; Kelkar, AA | 1 |
| Agostini, D; Matsuo, S; Nakajima, K; Okuda, K | 1 |
| Matsuo, S; Nakajima, K; Nakata, T | 1 |
| Cerqueira, MD; Hachamovitch, R; Menon, V; Nutter, B | 1 |
| Goldberger, JJ; Hendel, RC | 1 |
| Jacobson, AF; Matsuo, S; Nakajima, K; Nakata, T | 1 |
| Berukstis, A; Burneikaite, G; Gargalskaite, U; Laucevicius, A; Miglinas, M; Misonis, N; Vajauskas, D; Zakarkaite, D | 1 |
| Carrió, I; Folks, RD; Garcia, EV; Henzlova, MJ; Jacobson, AF; Jain, D; Travin, MI; van Eck-Smit, BLF; Verberne, HJ | 1 |
| Cascini, GL; Cipullo, S; Cuda, G; Curcio, A; De Rosa, S; Indolfi, C; Pasceri, E; Saccomanno, M; Santarpia, G; Veneziano, C | 1 |
| Jacobson, AF; Johnson, M; Levy, WC; O'Day, K | 1 |
| Azevedo, JC; Ferreira, AG; Maróstica, E; Mesquita, CT; Messias, AC; Messias, LR; Miranda, SM; Teixeira, JA | 1 |
| Fukuhara, E; Fukunami, M; Furukawa, Y; Hakui, H; Ikeda, I; Ishimi, M; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Ozaki, T; Sakata, Y; Sato, Y; Seo, M; Tamaki, S; Yamada, T | 1 |
| Attena, E; Cannavo, A; Cuocolo, A; de Lucia, C; Dellegrottaglie, S; Femminella, GD; Ferrara, N; Filardi, PP; Formisano, R; Komici, K; Leosco, D; Memmi, A; Pagano, G; Paolillo, S; Parisi, V; Pellegrino, T; Petraglia, L; Rengo, G; Trimarco, B; Vitale, DF | 1 |
| Adachi, H; Hoshizaki, H; Kan, H; Kasama, S; Kawaguti, R; Miyaishi, Y; Ohsima, S; Toyama, T; Yamashita, E | 1 |
| Jacobson, AF; Travin, MI; Tseng, C; White, S | 1 |
| Jacobson, AF; Matsunari, I; Nakajima, K | 1 |
| Alves, CR; Mesquita, CT; Muradas, MC; Nóbrega, AC; Porto, P; Precht, BC; Souza, JS; Teixeira, JA; Ubaldo, L; Villacorta, AS; Villacorta, H | 1 |
| Carrio, I; Flotats, A | 1 |
| Grabowski, ZP; Isaksen, K; Larsen, AI; Munk, PS; Valborgland, T | 1 |
| Gebhard, C | 1 |
| Doi, T; Hashimoto, A; Nakata, T; Yuda, S | 1 |
| Arimoto, T; Harada, M; Ikeno, E; Kubota, I; Nisugi, K; Sukekawa, H; Takayama, S; Takeishi, Y | 1 |
| Fujii, T; Fujimoto, K; Hanaoka, M; Kobayashi, T; Koizumi, T; Kubo, K; Urushihata, K | 1 |
| Almenar Bonet, L; Martinez-Dolz, L; Mateo Navarro, A; Mut Dólera, T; Olivas Arroyo, C; Ruiz Llorca, C; Salvador, A; Vercher Conejero, JL | 1 |
| Agostini, D; Hamon, M; Jacobson, AF; Manrique, A; Verberne, HJ | 1 |
| Jacobson, AF; Povinec, P; Somsen, GA; van Eck-Smit, BL; Verberne, HJ | 1 |
| Somsen, GA; van Eck-Smit, BL; Verberne, HJ | 1 |
| Heston, TF; Wahl, RL | 1 |
| Flevari, P; Georgiadis, M; Katsikis, A; Koutelou, M; Kremastinos, D; Livanis, E; Theodorakis, G; Voudris, V | 1 |
| Amino, M; Fukushima, T; Inokuchi, S; Kodama, I; Morita, S; Nakagawa, Y; Otsuka, H; Sakurai, K; Suzuki, Y; Tanabe, T; Uemura, S; Yamamoto, I; Yoshioka, K | 1 |
| Akutsu, Y; Asano, T; Gokan, T; Hamazaki, Y; Kaneko, K; Kawamura, M; Kobayashi, Y; Kodama, Y; Li, HL; Shinozuka, A; Suyama, J; Tanno, K | 1 |
| Despas, F; Galinier, M; Guerriero, E; Pathak, A; Senard, J | 1 |
| Athanasoulis, T; Diakos, N; Drakos, SG; Koudoumas, D; Malliaras, KG; Nanas, JN; Ntalianis, AS; Terrovitis, JV; Theodoropoulos, SP; Yacoub, MH | 1 |
| Baliga, RR; Chandrashekhar, Y; Haider, N; Narula, J | 1 |
| Camici, PG; Carrió, I; Cowie, MR; Udelson, J; Yamazaki, J | 1 |
| Agostini, D; Cerqueira, MD; Chandna, H; Jacobson, AF; Lopez, VA; Narula, J; Senior, R; Thomas, GS; Weiland, F; Wong, ND | 1 |
| Cobbe, SM; Fletcher, AM; Goodfield, NE; Martin, W; McCurrach, GM; Motherwell, DW; Petrie, MC; Small, AD | 1 |
| Johnson, MN; Schöder, H; Strauss, HW; Tamaki, N | 1 |
| Ando, M; Hino, A; Matsuzaki, M; Nakamura, Y; Sato, T; Yamamoto, T | 1 |
| Ando, S; Goto, Y; Kadota, J; Kawano, Y; Kotoku, M; Shinozaki, K; Tamura, A | 1 |
| Cao, YM; François, F; Patrick, J | 1 |
| Arimoto, T; Funayama, A; Ishino, M; Katoh, S; Kubota, I; Kutsuzawa, D; Miyamoto, T; Miyashita, T; Netsu, S; Niizeki, T; Nishiyama, S; Nitobe, J; Shishido, T; Takahashi, H; Watanabe, T | 1 |
| Pitt, B | 1 |
| Horie, M; Inubushi, T; Matsumoto, T; Mitsunami, K; Morikawa, S; Nakae, I; Omura, T; Tsutamoto, T; Yoshino, T | 1 |
| Amanullah, A; Ananthasubramaniam, K; Caldwell, JH; Clements, IP; Gerson, MC; Henzlova, MJ; Jacobson, AF | 1 |
| Kuwabara, Y; Nakata, T; Tamaki, N; Yamashina, S; Yamazaki, J | 1 |
| Cao, Q; Chen, W; Dilsizian, V | 1 |
| Akutsu, Y; Gokan, T; Hamazaki, Y; Kaneko, K; Kobayashi, Y; Kodama, Y; Li, HL; Shinozuka, A; Suyama, J; Tanno, K | 1 |
| Crawford, MH | 1 |
| Fukunami, M; Furukawa, Y; Iwasaki, Y; Kawasaki, M; Komuro, I; Kuramoto, Y; Levy, WC; Morita, T; Okada, T; Okuyama, Y; Tamaki, S; Tanaka, K; Ueda, H; Yamada, T; Yasui, T | 1 |
| Hage, FG; Iskandrian, AE | 1 |
| Ambrósio Gava, I; Campos Rodrigues, R; Cunha de Azevedo, J; de Queiroz Carreira, MÂ; Lucas da Nóbrega, AC; Maróstica, E; Ribeiro de Miranda, SM; Rocha Messias, L; Tinoco Mesquita, C | 1 |
| Isilak, Z; Kardesoglu, E; Uz, O; Yiginer, O | 1 |
| Salih, A | 1 |
| Fujimoto, S; Hisatake, S; Nakano, H; Namiki, A; Nanjo, S; Yamashina, S; Yamazaki, J; Yuzawa, H | 1 |
| Casaretti, L; Cecere, M; Cuocolo, A; Dellegrottaglie, S; Gargiulo, P; Marciano, C; Musella, F; Paolillo, S; Parente, A; Perrone-Filardi, P; Pirozzi, E; Savarese, G | 1 |
| Currie, GM; Iqbal, B; Jelinek, HF; Kiat, H; Trifunovic, M; Wang, L; Wheat, JM | 1 |
| Fujiwara, S; Fukuda, Y; Hirata, K; Kaneko, A; Kawai, H; Matsumoto, K; Ryo, K; Shigeru, M; Tanaka, H; Tatsumi, K; Tsuji, T; Yoshida, A | 1 |
| Hara, M; Nakagawa, M; Okada, N; Saikawa, T; Shinohara, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Chen, J; Folks, RD; Garcia, EV; Jacobson, AF; Manatunga, DN; Verdes, L | 1 |
| Abdallah, M; Gerson, MC | 1 |
| Bologna, A; Casaretti, L; Conte, S; Formisano, R; Losco, T; Mattiello, G; Mosca, S; Musella, F; Parente, A; Perrone-Filardi, P; Pirozzi, E; Savarese, G | 1 |
| Beller, GA; Janardhanan, R | 1 |
| Ichikawa, S; Iwasaki, T; Kaneko, Y; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
| Azevedo, JC; Gava, IA; Maróstica, E; Mesquita, CT; Messias, LR; Miranda, SM; Queiroz Carreira, MA; Rodrigues, RC | 1 |
| Bulten, BF; de Geus-Oei, LF; Kapusta, L; Mavinkurve-Groothuis, AM; van der Palen, RL; van Laarhoven, HW | 1 |
| Al Younis, I; Bax, JJ; Boogers, MJ; Dibbets-Schneider, P; Meinardi, JE; Scholte, AJ; Van der Wall, EE; Veltman, CE | 1 |
| Cheetham, A; George, RS; Kelion, AD; Marshall, A; Mason, M | 1 |
| Kamalakkannan, G; Travin, MI | 1 |
| Agostini, D; Caldwell, JH; Cerqueira, MD; Jacobson, AF; Ketchum, ES; Levy, WC; Narula, J; Senior, R; Thomas, GS | 1 |
| Dunlap, SH; Gerson, MC; Waqar, F | 1 |
| Bourgoun, M; Jacobson, AF; Narula, J; Shah, AM; Solomon, SD | 1 |
| Bengel, FM; Thackeray, JT | 1 |
| Bruno, I; Giordano, A; Stefanelli, A; Treglia, G | 1 |
| Brodov, Y; Frenkel, A; Israel, O; Keidar, Z; Kuptzov, E; Rispler, S | 1 |
| de Groot, AC; de Milliano, PA; Lie, KI; Tijssen, JG; van Eck-Smit, BL; Van Zwieten, PA | 2 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 4 |
| Asai, M; Fukunami, M; Hirata, A; Hoki, N; Hori, M; Kioka, H; Kumagai, K; Kusuoka, H; Makino, N; Ogita, H; Shimonagata, T; Yamada, T | 1 |
| Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y | 1 |
| Karkavitsas, NS; Nikitovic, D; Papadimitriou, E; Parthenakis, FI; Patrianakos, A; Prassopoulos, V; Vardas, PE | 1 |
| Liang, CS | 2 |
| Hirosaka, A; Ishihata, T; Komatsu, N; Maehara, K; Maruyama, Y; Onuki, N; Otani, H; Saito, T; Sato, M; Yaoita, H | 1 |
| Gerson, MC; McGuire, N; Wagoner, LE | 1 |
| Fujiwara, S; Kimura, T; Miura, M; Mori, S; Seiji, K; Wada, Y | 1 |
| Adachi, Y; Azuma, A; Ito, K; Kato, S; Matsubara, H; Nishikawa, S; Sugihara, H | 1 |
| Hashimoto, A; Kyuma, M; Nagao, K; Nakata, T; Sasao, H; Shimamoto, K; Takahashi, T; Tsuchihashi, K | 1 |
| Yamashina, S; Yamazaki, J | 1 |
| Arimoto, T; Fukui, A; Hirono, O; Itoh, M; Kubota, I; Miyamoto, T; Nozaki, N; Okada, A; Tachibana, H; Takahashi, H; Takahashi, K; Takeishi, Y; Yamaguchi, H | 1 |
| Ichikawa, S; Ishikawa, T; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Hamada, M; Hara, Y; Hiasa, G; Ogimoto, A; Ohtsuka, T; Saeki, H; Shigematsu, Y | 1 |
| Kyuma, M; Nakata, T; Shimamoto, K; Takahashi, T; Tsuchihashi, K; Wakabayashi, T | 1 |
| Amano, H; Fujimoto, S; Inoue, A; Ishida, S; Nakano, H; Yamashina, H; Yamashina, S; Yamazaki, J | 1 |
| Fujimoto, S; Hisatake, S; Inoue, A; Nakano, H; Yamashina, H; Yamashina, S; Yamazaki, J | 1 |
| Gimelli, A; Giorgetti, A; Kusch, A; L'abbate, A; Marini, C; Marzullo, P; Sambuceti, G; Sereni, N | 1 |
| Bax, JJ; De Bruin, R; De Winter, RJ; Erol-Yilmaz, A; Hrudova, J; Schalij, MJ; Schrama, TA; Tukkie, R; Van Eck-Smit, BL; Verberne, HJ; Wilde, AA | 1 |
| Anastasiou-Nana, MI; Athanasoulis, T; Efentakis, S; Geramoutsos, A; Karaloizos, L; Nanas, JN; Pappa, L; Terrovitis, JV; Tsagalou, EP | 1 |
| Fujino, N; Fujita, T; Funada, A; Ikeda, H; Ino, H; Kaneda, T; Kato, H; Konno, T; Mabuchi, H; Mabuchi, T; Masuda, E; Shimizu, M; Terai, H; Uchiyama, K | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Bocchi, EA; Chizzola, PR; Gonçalves de Freitas, HF; Mansur, JA; Marinho, NV; Meneghetti, JC | 1 |
| Dohmori, T; Fukutomi, T; Kondo, H; Ogata, M; Sugiura, M; Suzuki, S; Takeda, Y; Yamamoto, K | 1 |
| Arimoto, T; Hirono, O; Koyama, Y; Kubota, I; Miyashita, T; Niizeki, T; Nozaki, N; Okada, A; Okuyama, H; Shishido, T; Takahashi, K; Takeishi, Y; Tsunoda, Y | 1 |
| Cobbe, SM; Martin, W; Motherwell, DW; Petrie, MC | 1 |
| Dilsizian, V; Shirani, J | 1 |
| Arimoto, T; Hirono, O; Kitahara, T; Koyama, Y; Kubota, I; Niizeki, T; Nitobe, J; Nozaki, N; Okada, A; Suzuki, S; Takahashi, K; Takeishi, Y; Tsunoda, Y; Watanabe, T | 1 |
| Fukunami, M; Hori, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T | 1 |
| Bax, JJ; Henneman, MM; van der Wall, EE | 1 |
| Fukuma, N; Kato, K; Kato, Y; Kumita, S; Oikawa, K; Takano, T; Tsuchida, T | 1 |
| Nakata, T; Wakabayashi, T | 1 |
| Duffy, SJ; Gould, PA; Kalff, V; Kaye, DM; Kelly, MJ; Kong, G; Taylor, AJ | 1 |
| Dos-Santos, P; Labrousse, L; Réant, P; Valli, N | 1 |
| Agostini, D; Habraken, JB; Jacobson, AF; van Eck-Smit, BL; Verberne, HJ | 1 |
| Inubushi, M; Katoh, C; Kuge, Y; Morita, K; Naya, M; Nishijima, K; Okamoto, H; Tamaki, N; Tsukamoto, T; Tsutsui, H | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Kasanuki, H; Kobayashi, H; Kusakabe, K; Momose, M; Nagamatsu, H | 1 |
| Dimski, T; Heinen-Lauten, J; Krep, H | 1 |
| Agostini, D; Banerjee, G; Burchert, W; Estorch, M; Jacobson, AF; Knuuti, J; Povinec, P; Sambuceti, G; Unlu, M; Verberne, HJ | 1 |
| Bax, JJ; Boogers, M; Henneman, MM | 1 |
| Brewster, LM; Somsen, GA; van Eck-Smit, BL; Verberne, HJ | 1 |
| Fujii, M; Horie, M; Nakae, I; Nishiyama, K; Ohnishi, M; Sakai, H; Tanaka, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Asirvatham, SJ; Cha, YM; Chareonthaitawee, P; Chen, PS; Hayes, DL; Hodge, DO; Kemp, BJ; Miyazaki, C; Oh, J; Rea, RF; Shen, WK | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Nakazawa, M; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Gallego-Page, JC | 1 |
| Inoue, M; Tazawa, S; Wakasugi, S | 1 |
| Ando, H; Ashihara, T; Egashira, S; Fukuyama, T; Imamura, Y; Masaki, H; Mitsuoka, W | 1 |
| Benvenuti, C; Castaigne, A; Deleuze, PH; Dubois-Randé, JL; Hillion, ML; Loisance, D; Mazzucotelli, JP; Merlet, P; Syrota, A | 1 |
| Azuma, A; Ito, K; Kohno, Y; Miyao, K; Nakagawa, M; Ohtsuki, K; Shiga, K; Sugihara, H; Taniguchi, Y; Terada, K | 1 |
| Asada, S; Kusuoka, H; Morozumi, R; Nishimura, T; Yabunouchi, T; Yamamoto, K | 1 |
| Amidon, TM; Dae, M; De Marco, T; Keith, F; Klinski, C; Kumar, S; Lau, D; Rifkin, C; Sudhir, K; Yuen-Green, MS | 1 |
| Nishimura, T | 1 |
| Honda, M; Kurihara, T; Murano, K; Narita, M; Usami, M | 1 |
| Armstrong, PW; Freeman, MR; Grima, EA; Hsia, TW; Simmons, WW | 1 |
| Abrahamowicz, M; Castilla, EP; Chen, LF; Fitchett, DH; Gomez, AA; Honos, GN; Rabinovitch, MA; Rose, CP; Schwab, AJ; Stewart, JA | 1 |
| Borm, JJ; de Milliano, PA; Dubois, EA; Somsen, GA; van Royen, EA; van Vlies, B | 1 |
| Inagaki, S; Kageyama, M; Kakishita, M; Nozawa, T; Seto, H; Shimizu, M; Yoshida, N | 1 |
| Ando, H; Ashihara, T; Fukuyama, T; Imamura, Y | 1 |
| Batink, HD; Brandsma, K; de Jong, J; Dubois, EA; Lie, KI; Somsen, GA; van der Wouw, PA; van Royen, EA; van Zwieten, PA | 1 |
| Borm, JJ; de Milliano, PA; Endert, E; Lie, KI; Somsen, GA; van Royen, EA; van Vlies, B | 1 |
| Borm, JJ; Dubois, EA; Schook, MB; Somsen, GA; Van Der Wall, EE; Van Royen, EA | 1 |
| Borm, JJ; Somsen, GA; van der Wall, EE; van Royen, EA; van Vlies, B | 1 |
| Castaigne, A; Dubois-Randé, JL; Loisance, D; Merlet, P; Piot, O; Syrota, A | 1 |
| Fukuyama, T; Imamura, Y | 1 |
| Atsumi, H; Fujiwara, S; Takahashi, K; Takeishi, Y; Tomoike, H | 1 |
| de Groot, CA; de Milliano, PA; Lie, KI; Somsen, GA; Szabó, BM; van Veldhuisen, DJ | 1 |
| Nishimura, T; Sasaki, Y; Sugishita, Y | 1 |
| Agostini, D; Amar, MH; Babatasi, G; Belin, A; Bouvard, G; Grollier, G; Lecluse, E; Potier, JC | 1 |
| Kurihara, T; Narita, M | 1 |
| Atsumi, H; Fujiwara, S; Takeishi, Y; Tomoike, H | 1 |
| Chikama, H; Demachi, J; Goto, A; Ikeda, J; Li, S; Sekiguchi, Y; Shirato, K; Takita, T | 1 |
| Castaigne, A; Delahaye, N; Dubois-Randé, JL; Fumey, R; Merlet, P; Pouillart, F; Syrota, A | 1 |
| Cohen-Solal, A; Dreyfus, G; Dubois, C; Esanu, Y; Gourgon, R; Logeart, D; Merlet, P; Pessione, F | 1 |
| Bandou, K; Fukuda, N; Shinohara, H; Soeki, T; Sui, O; Takeichi, N; Tamura, Y; Tanaka, H; Yui, Y | 1 |
| Kronenberg, MW | 1 |
| Asanoi, H; Fujii, N; Igawa, A; Inoue, H; Inoue, M; Nozawa, T; Tazawa, S; Yoshida, N | 1 |
| Aoki, S; Makino, K; Nomura, Y; Okamoto, R; Okamoto, S; Saitou, K; Takeda, K; Yahara, Y | 1 |
| Hartikainen, J; Jantunen, E; Kuikka, J; Nousiainen, T; Remes, J; Vanninen, E | 1 |
| Ayusawa, M; Harada, K; Karasawa, K; Noto, N; Okada, T; Sumitomo, N | 1 |
| Fukuyama, T; Imamura, Y; Miyagawa, M; Mochizuki, T; Watanabe, K | 1 |
| Azegami, K; Itoh, K; Okishige, K; Sasano, T; Suzuki, K; Yano, K | 1 |
| L'Abbate, A; Sambuceti, G | 1 |
| Fukushima, N; Horiguchi, K; Matsuda, H; Matsumiya, G; Miyagawa, S; Nishimura, M; Ohtake, S; Sawa, Y; Taketani, S | 1 |
| Asai, M; Asano, Y; Fukunami, M; Hirata, A; Hoki, N; Hori, M; Kumagai, K; Kusuoka, H; Ogita, H; Shimonagata, T; Yamada, T | 1 |
| Kinoshita, M; Matsui, T; Tsutamoto, T | 1 |
| de Milliano, PA; Lie, KI; Tijssen, JG; van Eck-Smit, BL | 1 |
| Kinoshita, M; Kusukawa, J; Maeda, K; Matsui, T; Tsutamoto, T | 1 |
| Adnot, S; Benvenuti, C; Bourguignon, MH; Castaigne, A; Dubois-Randé, JL; Loisance, D; Merlet, P; Syrota, A; Valette, H | 1 |
| Dec, GW | 1 |
| Agostini, D; Benvenuti, C; Bourguignon, MH; Dove, P; Duboc, D; Dubois-Randé, JL; Duval, AM; Merlet, P; Moyse, D; Valette, H | 1 |
| Bedotto, JB; Corbett, JR; Deitchman, D; Eichhorn, EJ; Grayburn, PA; Hatfield, BA; Malloy, CR; McGhie, AL; Willard, JE | 1 |
| Hasegawa, Y; Nakano, S; Shibata, N; Wada, A; Wakasugi, S | 1 |
| Strashun, A | 1 |
| Hori, M; Ishida, Y; Kamada, T; Kimura, K; Kitabatake, A; Matsuyama, T; Morozumi, T; Ozaki, H; Sato, H; Tani, A | 1 |
39 review(s) available for 3-iodobenzylguanidine and Heart Failure
| Article | Year |
|---|---|
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Heart; Heart Failure; Humans; Radiopharmaceuticals; Sympathetic Nervous System | 2023 |
Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear Techniques.
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Sympathetic Nervous System | 2022 |
[123 I-MIBG scintigraphy in the assessment of heart failure prognosis and effectiveness of cardiac resynchronization therapy].
Topics: 3-Iodobenzylguanidine; Cardiac Resynchronization Therapy; Heart; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2019 |
The prognostic value of
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart Failure; Humans; Iodine Radioisotopes; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2022 |
Myocardial
Topics: 3-Iodobenzylguanidine; Animals; Baroreflex; Disease Models, Animal; Echocardiography; Heart; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Ischemia; Myocardium; Prognosis; Risk Factors; Sympathetic Nervous System; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2018 |
New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Catecholamines; Death, Sudden, Cardiac; Disease Models, Animal; Ephedrine; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Sympathetic Nervous System; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure.
Topics: 3-Iodobenzylguanidine; Ephedrine; Heart; Heart Failure; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2020 |
Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Preoperative Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System | 2013 |
A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Chi-Square Distribution; Databases as Topic; Disease Progression; Evidence-Based Medicine; Female; Heart; Heart Failure; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; ROC Curve; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2013 |
Cardiac metaiodobenzylguanidine imaging and heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Drug Monitoring; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment | 2013 |
The clinical value of cardiac sympathetic imaging in heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2014 |
Myocardial innervation and perfusion imaging during LVAD implantation: a nuclear imaging approach.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Heart-Assist Devices; Humans; Myocardium; Perfusion Imaging; Positron-Emission Tomography; Treatment Outcome | 2014 |
For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis.
Topics: 3-Iodobenzylguanidine; Cause of Death; Chronic Disease; Endpoint Determination; Female; Heart Failure; Humans; Male; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed, Single-Photon | 2014 |
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotoxicity; Death, Sudden, Cardiac; Ephedrine; Heart; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Prognosis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2015 |
[Scintigraphy of the heart using noradrenaline has a prognostic value when visualising heart failure].
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Heart Failure; Humans; Myocardial Perfusion Imaging; Radiopharmaceuticals | 2014 |
Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.
Topics: 3-Iodobenzylguanidine; Amines; Amiodarone; Animals; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Cardiology; Cell Line; Cell Line, Tumor; Diagnostic Imaging; Drug Interactions; Heart; Heart Failure; Humans; Iodine Radioisotopes; Labetalol; Norepinephrine; Radiopharmaceuticals; Receptors, Adrenergic; Reproducibility of Results; Reserpine; Risk; Selective Serotonin Reuptake Inhibitors; Sympathetic Nervous System | 2015 |
Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
Topics: 3-Iodobenzylguanidine; Cardiology; Decision Making; Heart; Heart Failure; Heart Transplantation; Humans; Japan; Phantoms, Imaging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Societies, Medical; Tomography, Emission-Computed, Single-Photon | 2015 |
123I-MIBG SPECT for Evaluation of Patients with Heart Failure.
Topics: 3-Iodobenzylguanidine; Animals; Diagnostic Imaging; Heart Failure; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2015 |
Clinical Applications of Myocardial Innervation Imaging.
Topics: 3-Iodobenzylguanidine; Cardiac Imaging Techniques; Heart; Heart Failure; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Usefulness of Cardiac Sympathetic Nerve Imaging Using (123)Iodine-Metaiodobenzylguanidine Scintigraphy for Predicting Sudden Cardiac Death in Patients With Heart Failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2016 |
Current Clinical Applications and Next Steps for Cardiac Innervation Imaging.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Defibrillators, Implantable; Heart; Heart Failure; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sympathetic Nervous System | 2017 |
Cardiac 123I-MIBG scintigraphy in heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Myocardium; Prognosis; Prospective Studies; Radionuclide Imaging | 2008 |
Cardiac sympathetic imaging with mIBG in heart failure.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Tomography, Emission-Computed; Treatment Outcome | 2010 |
Determination of the survival rate in patients with congestive heart failure stratified by ¹²³I-MIBG imaging: a meta-analysis from the studies performed in Japan.
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Japan; Prognosis; Radionuclide Imaging; Survival Rate; Time Factors | 2011 |
Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Mediastinum; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Time Factors | 2011 |
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal.
Topics: 3-Iodobenzylguanidine; Disease Progression; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System | 2011 |
Risk stratification in heart failure using ¹²³I-MIBG.
Topics: 3-Iodobenzylguanidine; Aged; Defibrillators, Implantable; Heart Failure; Humans; Male; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, Emission-Computed, Single-Photon | 2011 |
[Clinical applications of MIBG SPECT in chronic heart failure].
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Radionuclide imaging in stage B heart failure.
Topics: 3-Iodobenzylguanidine; Asymptomatic Diseases; Cardiomyopathies; Chronic Disease; Coronary Artery Disease; Glucose; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Prognosis; Radionuclide Ventriculography; Radiopharmaceuticals; Sarcoidosis; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2012 |
What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?
Topics: 3-Iodobenzylguanidine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Humans; Meta-Analysis as Topic; Mineralocorticoid Receptor Antagonists; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2012 |
Assessment of cardiac autonomic neuronal function using PET imaging.
Topics: 3-Iodobenzylguanidine; Animals; Autonomic Nervous System; Heart; Heart Failure; Humans; Ligands; Myocardial Infarction; Myocardial Ischemia; Neurons; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2013 |
Cardiac autonomic imaging with SPECT tracers.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Autonomic Nervous System; Heart; Heart Failure; Humans; Myocardial Ischemia; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Risk; Tomography, Emission-Computed, Single-Photon | 2013 |
Clinical usefulness of myocardial innervation imaging using Iodine-123-meta-iodobenzylguanidine scintigraphy in evaluating the effectiveness of pharmacological treatments in patients with heart failure: an overview.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Heart; Heart Failure; Humans; Iodine Radioisotopes; Mineralocorticoid Receptor Antagonists; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Molecular imaging in heart failure.
Topics: 3-Iodobenzylguanidine; Adenoviridae; beta-Galactosidase; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Heart Failure; Humans; Luciferases; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[Cardiac sympathetic nerve function assessed by 12I-labeled metaiodobenzylguanidine (MIBG) scintigraphic imaging].
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Radionuclide Imaging; Sympathetic Nervous System | 2007 |
Cardiac sympathetic nerve terminal function in congestive heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Sympathetic Nervous System | 2007 |
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Mediastinum; Meta-Analysis as Topic; Middle Aged; Myocardium; Prognosis; Radiopharmaceuticals; Survival Analysis | 2008 |
[Radionuclide assessment of heart failure].
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Coronary Circulation; Gated Blood-Pool Imaging; Heart Failure; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Myocardium; Necrosis; Stroke Volume | 1993 |
Clinical use of metaiodobenzylguanidine imaging in cardiology.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Anthracyclines; Arrhythmias, Cardiac; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Heart; Heart Diseases; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Long QT Syndrome; Myocardial Infarction; Myocardial Ischemia; Myocardium; Norepinephrine; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Synaptic Transmission; Tachycardia, Ventricular; Tissue Survival; Ventricular Dysfunction, Right | 1995 |
47 trial(s) available for 3-iodobenzylguanidine and Heart Failure
| Article | Year |
|---|---|
Prognostic usefulness of planar
Topics: 3-Iodobenzylguanidine; Aged; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stroke Volume; Survival Analysis; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed, Single-Photon | 2021 |
Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction.
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Stroke Volume; Tolvaptan; Ventricular Function, Left | 2020 |
Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Cardiac Resynchronization Therapy; Female; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 2019 |
Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Resynchronization Therapy; Cohort Studies; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2020 |
Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Female; Haplotypes; Heart; Heart Failure; Hemostasis; Humans; Male; Metoprolol; Middle Aged; Patient Selection; Propanolamines; Radionuclide Imaging; Receptors, Adrenergic, beta-2; Sympathetic Nervous System; Treatment Outcome | 2013 |
Efficacy of thyroid blockade on thyroid radioiodine uptake in 123I-mIBG imaging.
Topics: 3-Iodobenzylguanidine; Aged; Case-Control Studies; Drug Administration Schedule; Female; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Observer Variation; Perchlorates; Pilot Projects; Potassium Iodide; Prospective Studies; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Thyroid Gland; Thyroid Hormones; Time Factors; Tomography, Emission-Computed, Single-Photon | 2014 |
An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators.
Topics: 3-Iodobenzylguanidine; Algorithms; Equipment Design; Equipment Failure Analysis; Female; Heart; Heart Failure; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Mediastinum; Myocardium; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System | 2014 |
¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Female; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Liver; Lung; Male; Mediastinum; Middle Aged; Multivariate Analysis; Myocardial Perfusion Imaging; Photons | 2015 |
1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Heart Failure; Humans; Male; Metabolic Clearance Rate; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Gland; Tomography, Emission-Computed, Single-Photon | 2016 |
Prognostic Value of Cardiac Sympathetic Nerve Imaging Using Long-Term Follow-up Data - Ischemic vs. Non-Ischemic Heart Failure Etiology.
Topics: 3-Iodobenzylguanidine; Aged; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Neuroimaging; Prospective Studies; Survival Rate; Sympathetic Nervous System | 2016 |
Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cheyne-Stokes Respiration; Chronic Disease; Exercise; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Respiration, Artificial; Sympathetic Nervous System | 2017 |
Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG Myocardial Scintigraphy Study.
Topics: 3-Iodobenzylguanidine; Adult; Cardiovascular Agents; Chronic Disease; Denervation; Exercise Test; Female; Heart; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Radionuclide Imaging; Sympathetic Nervous System | 2016 |
Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy : A randomized Iodine-123 metaiodobenzylguanidine scintigraphy study.
Topics: 3-Iodobenzylguanidine; Aged; Exercise; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Radiopharmaceuticals; Sympathetic Nervous System | 2018 |
Short cardiac iodine-123-metaiodobenzylguanidine imaging protocol in heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2008 |
Predictive value of cardiac autonomic indexes and MIBG washout in ICD recipients with mild to moderate heart failure.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Defibrillators, Implantable; Female; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pressoreceptors; Tachycardia | 2009 |
Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Diagnostic Imaging; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Risk; Stroke Volume | 2010 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides | 2011 |
Effect of left ventricular dyssynchrony on cardiac sympathetic activity in heart failure patients with wide QRS duration.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Resynchronization Therapy; Echocardiography; Electrocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake.
Topics: 3-Iodobenzylguanidine; Aged; Algorithms; Diagnosis, Differential; Female; Heart; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Myocardium; Pilot Projects; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Double-Blind Method; Down-Regulation; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Myocardium; Presynaptic Terminals; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2002 |
Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Radiopharmaceuticals; Spironolactone; Stroke Volume; Sympathetic Nervous System | 2002 |
Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Ventricular Function, Left | 2003 |
Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Tetrazoles; Treatment Outcome; Ultrasonography; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Rest; Statistics as Topic; Ventricular Dysfunction, Left | 2003 |
Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Sympathetic Nervous System | 2003 |
Dynamic 123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Cardiotonic Agents; Chronic Disease; Disease-Free Survival; Female; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Severity of Illness Index; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents | 2004 |
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinations; Female; Furosemide; Heart; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Drug Combinations; Female; Heart Failure; Humans; Japan; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac function.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Cardiomyopathies; Causality; Comorbidity; Female; Heart Failure; Humans; Incidence; Japan; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sex Distribution; Survival Analysis; Tomography, Emission-Computed, Single-Photon | 2004 |
Usefulness of meta-[123I]iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy who receive long-term beta blocker treatment.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disease-Free Survival; Female; Heart Failure; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Prevalence; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Survival Analysis | 2005 |
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiac Volume; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Stroke Volume; Tetrazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 2005 |
Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Cardiomyopathy, Dilated; Coronary Artery Disease; Heart; Heart Failure; Humans; Male; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2005 |
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Female; Heart Failure; Heart Ventricles; Humans; Male; Perindopril; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome | 2005 |
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Heart; Heart Failure; Humans; Male; Mediastinum; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tetrazoles; Valine; Valsartan | 2006 |
The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Double-Blind Method; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Fatty Acid-Binding Proteins; Female; Heart Failure; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic; Sympathetic Nervous System | 2005 |
Improvement in cardiac adrenergic function post biventricular pacing for heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Blood Pressure; Cardiac Pacing, Artificial; Cross-Over Studies; Double-Blind Method; Female; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic; Sympathetic Nervous System | 2007 |
Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Synergism; Echocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Spironolactone; Sympathetic Nervous System; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Perindopril; Radionuclide Imaging; Risk Factors; Stroke Volume; Sympathetic Nervous System; Treatment Outcome | 2008 |
Cardiac resynchronization therapy upregulates cardiac autonomic control.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System; Defibrillators, Implantable; Electrocardiography, Ambulatory; Feedback; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2008 |
[Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
Topics: 3-Iodobenzylguanidine; Aged; Aortic Valve Insufficiency; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Insufficiency; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1995 |
Impact of exercise rehabilitation on cardiac neuronal function in heart failure: an iodine-123 metaiodobenzylguanidine scintigraphy study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Therapy; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurons; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Function, Left | 1998 |
Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Blood Pressure; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 1998 |
Long-term effects of the angiotensin-converting enzyme inhibitor enalapril on chronic heart failure. Examination by 123I-MIBG imaging.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Chronic Disease; Enalapril; Female; Heart Failure; Humans; Hypertension; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 1998 |
Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiomyopathies; Death; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Cardiac 123 I-MIBG imaging and clinical variables in risk stratification in patients with heart failure treated with beta blockers.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Metoprolol; Norepinephrine; Oxygen Consumption; Predictive Value of Tests; Prospective Studies; Radionuclide Ventriculography; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume | 2002 |
Effects of bucindolol on neurohormonal activation in congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Heart; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Norepinephrine; Propanolamines; Radionuclide Imaging; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1991 |
204 other study(ies) available for 3-iodobenzylguanidine and Heart Failure
| Article | Year |
|---|---|
Prognostic Significance of Cardiac
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2022 |
Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.
Topics: 3-Iodobenzylguanidine; Aftercare; Heart Failure; Humans; Iodine Radioisotopes; Patient Discharge; Prognosis; Risk Assessment; Stroke Volume; Ventricular Function, Left | 2022 |
Can the promise of radionuclide cardiac innervation imaging be fulfilled?
Topics: 3-Iodobenzylguanidine; Diagnostic Imaging; Heart; Heart Failure; Humans; Radioisotopes; Sympathetic Nervous System | 2022 |
Cardiac sympathetic innervation and mortality risk scores in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Heart; Heart Failure; Humans; Prospective Studies; Radiopharmaceuticals; Risk Factors | 2023 |
How to best appreciate the possible clinical role of cardiac
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Iodine Radioisotopes; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2021 |
Evaluation of the arrhythmic risk in the 21st century: is multi-tracer nuclear imaging the answer?
Topics: 3-Iodobenzylguanidine; Defibrillators, Implantable; Heart; Heart Failure; Humans; Prognosis | 2020 |
Usefulness of 5 Minutes
Topics: 3-Iodobenzylguanidine; Brain; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2020 |
Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute H
Topics: 3-Iodobenzylguanidine; Heart Failure; Hospitalization; Humans; Iodine Radioisotopes; Prognosis; Prospective Studies; Registries; Stroke Volume; Ventricular Function, Left | 2021 |
The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Resynchronization Therapy; Female; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 2021 |
Renal iodine
Topics: 3-Iodobenzylguanidine; Aged; Echocardiography; Female; Heart Failure; Humans; Iodine Radioisotopes; Kidney; Male; Middle Aged; Muscles; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Ventricular Function, Left | 2020 |
Machine learning-based risk model using
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Death; Heart Failure; Humans; Iodine Radioisotopes; Machine Learning; Middle Aged; Stroke Volume; Ventricular Function, Left | 2022 |
Noradrenergic uptake in the liver on
Topics: 3-Iodobenzylguanidine; Aged; Diabetes Mellitus; Diagnostic Imaging; Female; Heart Failure; Humans; Iodine Radioisotopes; Liver; Male; Middle Aged; Radiopharmaceuticals | 2020 |
Prediction of appropriate ICD therapy in patients with ischemic heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Secondary Prevention; Tomography, Emission-Computed, Single-Photon | 2022 |
Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Prognosis; Radiopharmaceuticals | 2021 |
Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Heart; Heart Failure; Humans; Middle Aged; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Ventricular Function, Left | 2021 |
Changes in cardiac sympathetic nerve activity on
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2021 |
Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction.
Topics: 3-Iodobenzylguanidine; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Mediastinum; Obesity, Abdominal; Radiopharmaceuticals; Stroke Volume | 2022 |
Significance of
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2022 |
MIBG and imaging of cardiac adrenergic system: From heart failure to ventricular arrhythmias and atrial fibrillation, through cardiac asynchrony. What else?
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Atrial Fibrillation; Heart; Heart Failure; Humans | 2022 |
Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators.
Topics: 3-Iodobenzylguanidine; Heart Failure; Hospitalization; Humans; Hyperglycemia; Prognosis; Stroke Volume; Takotsubo Cardiomyopathy; Ventricular Function, Left | 2021 |
A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Natriuretic Peptide, Brain; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2022 |
Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Neurocardiac imaging has a proven value in patient management.
Topics: 3-Iodobenzylguanidine; Cardiac Imaging Techniques; Defibrillators, Implantable; Heart; Heart Failure; Humans; Stroke Volume | 2017 |
Neuro-cardiac imaging has a proven value in patient management: Con.
Topics: 3-Iodobenzylguanidine; Cardiac Imaging Techniques; Heart; Heart Failure; Humans; Myocardial Ischemia; Sympathetic Nervous System | 2017 |
Assessing arrhythmic risk with
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart; Heart Failure; Humans; Iodine Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2019 |
Clinical utility of cardiac innervation imaging in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Defibrillators, Implantable; Heart; Heart Failure; Humans; Tomography, Emission-Computed, Single-Photon; Uncertainty; Ventricular Function, Left | 2017 |
Transcatheter Aortic Valve Implantation Improves Cardiac Sympathetic Nerve Activity on
Topics: 3-Iodobenzylguanidine; Aged, 80 and over; Aortic Valve Stenosis; Female; Heart Failure; Hemodynamics; Humans; Male; Myocardial Perfusion Imaging; Prognosis; Sympathetic Nervous System; Transcatheter Aortic Valve Replacement | 2018 |
Neuronal damage and abnormal contraction: Is the circle of synchronicity complete?
Topics: 3-Iodobenzylguanidine; Autonomic Denervation; Cardiac Resynchronization Therapy; Heart Failure; Humans; Iodine Radioisotopes; Radionuclide Imaging; Stroke Volume | 2019 |
Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Area Under Curve; Cause of Death; Chronic Disease; Cohort Studies; Disease-Free Survival; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve; Survival Analysis | 2018 |
Cardiac adrenergic neuronal activity, sleep apnea, and potential therapeutic role of nocturnal ventilatory assistance in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Carbon Radioisotopes; Heart Failure; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Sleep Apnea Syndromes; Tomography, Emission-Computed, Single-Photon | 2019 |
Role of cardiac
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Chronic Disease; Defibrillators, Implantable; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Observer Variation; Prospective Studies; Radionuclide Imaging; Secondary Prevention; Tomography, Emission-Computed, Single-Photon | 2019 |
Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2019 |
Topics: 3-Iodobenzylguanidine; Cardiac Resynchronization Therapy; Heart Failure; Humans; Iodine Radioisotopes; Prognosis | 2020 |
Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients.
Topics: 3-Iodobenzylguanidine; Adult; Chagas Cardiomyopathy; Cross-Sectional Studies; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Primary Dysautonomias; Radionuclide Imaging; Radiopharmaceuticals | 2018 |
How do we establish cardiac sympathetic nervous system imaging with
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Heart Failure; Humans; Japan; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; United States | 2019 |
Cardiac innervation imaging as a risk stratification tool for potential device therapy candidates.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Myocardium; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment | 2020 |
Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Defibrillators, Implantable; Female; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2020 |
Prognostic values of
Topics: 3-Iodobenzylguanidine; Aged; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2020 |
Heart rate and 123I-MIBG in heart failure with preserved ejection fraction: More variability and slower washout-A secret recipe for better survival.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Heart Rate; Humans; Iodine Radioisotopes; Myocardial Perfusion Imaging; Prognosis; Stroke Volume | 2020 |
Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity and cardiac events in patients with ischemic cardiomyopathy and mild to moderate heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Female; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Myocardial Ischemia; Prognosis; Sympathetic Nervous System; Treatment Outcome | 2019 |
Regional Cardiac Sympathetic Nervous System Evaluation Using 123I-mIBG SPECT in Patients with Heart Failure.
Topics: 3-Iodobenzylguanidine; Aged; Death, Sudden, Cardiac; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2018 |
Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Imaging Techniques; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Lung; Male; Middle Aged; Outcome Assessment, Health Care; Predictive Value of Tests; Radiopharmaceuticals; Stroke Volume; Survival Analysis; Survival Rate | 2021 |
Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardium; Prevalence; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
Importance of sympathetic nervous system activity during left ventricular functional recovery and its association with in-hospital complications in Takotsubo syndrome.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Heart Failure; Hospital Mortality; Humans; Logistic Models; Male; Multivariate Analysis; Radionuclide Imaging; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Takotsubo Cardiomyopathy; Ventricular Function, Left | 2019 |
Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Topics: 3-Iodobenzylguanidine; Aged; Biological Availability; Dose-Response Relationship, Drug; Female; Furosemide; Heart; Heart Failure; Humans; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2019 |
Cardiac sympathetic imaging in heart failure: Is revival possible?
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Lung | 2021 |
Association of heart failure duration with clinical prognosis in advanced heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Prospective Studies; Severity of Illness Index; Time Factors | 2020 |
Radiation-induced myocardial damage indicated by focal defect on
Topics: 3-Iodobenzylguanidine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiation Injuries; Tomography, Emission-Computed, Single-Photon | 2019 |
Prognostic value of cardiac metaiodobenzylguanidine imaging and QRS duration in implantable cardioverter defibrillator patients with and without heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Imaging Techniques; Defibrillators, Implantable; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Time Factors | 2019 |
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study.
Topics: 3-Iodobenzylguanidine; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2013 |
Do interleukin-1β levels correlate with MIBG and exercise parameters in heart failure?
Topics: 3-Iodobenzylguanidine; Adult; Aged; Epidemiologic Methods; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Interleukin-1beta; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume | 2013 |
Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects.
Topics: 3-Iodobenzylguanidine; Aged; Case-Control Studies; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Lung; Male; Mediastinum; Middle Aged; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis | 2013 |
Relationship between impaired cardiac sympathetic activity and spatial dyssynchrony in patients with non-ischemic heart failure: assessment by MIBG scintigraphy and tagged MRI.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Cardiac Resynchronization Therapy; Female; Heart; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Time Factors; Young Adult | 2013 |
Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart Failure; Humans; Male; Middle Aged; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2013 |
Outcome prediction in heart failure with atrial fibrillation: relative role of left ventricular ejection fraction and neurohormonal measures.
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hormones; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Proportional Hazards Models; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2013 |
Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Death; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nicorandil; Organ Size; Prognosis; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
Renal dysfunction does not affect the prognostic value of myocardial iodine-123 meta-iodobenzylguanidine imaging in heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Heart Failure; Humans; Kidney; Male; Middle Aged; Prognosis; Radionuclide Imaging | 2014 |
Impact of a predefined mediastinal ROI on inter-observer variability of planar ¹²³I-MIBG heart-to-mediastinum ratio.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Mediastinum; Myocardium; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide.
Topics: 3-Iodobenzylguanidine; Administration, Intravenous; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Organ Size; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Analysis of Variance; Chronic Disease; Death; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Radionuclide Imaging; Risk | 2014 |
Reconstruction of semiautomated cardiac regions of interest using iodine-123 metaiodobenzylguanidine myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Automation; Female; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Perfusion Imaging; Phantoms, Imaging; Reproducibility of Results | 2014 |
Relationship between quantitative cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine and hospitalization in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Female; Heart; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neurons; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
Cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions.
Topics: 3-Iodobenzylguanidine; Female; Heart; Heart Failure; Hospitalization; Humans; Male; Neurons; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
Myocardial sympathetic innervation imaging in heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Myocardium; Radionuclide Imaging; Sympathetic Nervous System; Technology Assessment, Biomedical; United States | 2014 |
The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Prognosis; Radionuclide Imaging; Risk Assessment; Systole | 2014 |
(123)I-mIBG scintigraphy: yet another risk stratifier for the heart failure toolbox!
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Female; Heart; Heart Failure; Humans; Male; Radionuclide Imaging | 2014 |
Statin therapy and cardiac sympathetic activity in patients with heart failure: a 123iodine-metaiodobenzylguanidine myocardial scintigraphy study.
Topics: 3-Iodobenzylguanidine; Female; Heart; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2014 |
Serial ¹²³I-metaiodobenzylguanidine imaging predicts the risk of sudden cardiac death in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Survival Rate | 2015 |
Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Polymorphism, Genetic; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic, beta-1 | 2014 |
Effects of statin therapy on cardiac sympathetic nerve activity and left ventricular remodeling in patients with chronic heart failure: a propensity score-matched analysis.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Echocardiography; Female; Heart Conduction System; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Propensity Score; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Ventricular Remodeling | 2014 |
Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Multimodal Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2016 |
Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Echocardiography, Transesophageal; Female; Heart Conduction System; Heart Failure; Humans; Insulin Resistance; Male; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2015 |
Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk; Ventricular Dysfunction, Left | 2015 |
Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Echocardiography, Three-Dimensional; Female; Heart Failure; Humans; Male; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2015 |
Have imagers aptly or inadvertently overlooked the neuronal myocardial compartment?
Topics: 3-Iodobenzylguanidine; Contrast Media; Densitometry; Diagnostic Imaging; Heart; Heart Failure; Humans; Molecular Imaging; Myocardium; Neurons; Norepinephrine Plasma Membrane Transport Proteins | 2015 |
Neuronal dysfunction and medical therapy in heart failure: can an imaging biomarker help to "personalize" therapy?
Topics: 3-Iodobenzylguanidine; Biomarkers; Clinical Trials as Topic; Heart; Heart Failure; Humans; Myocardium; Neurons; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System | 2015 |
An electrophysiologist perspective on risk stratification in heart failure: can better understanding of the condition of the cardiac sympathetic nervous system help?
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Autonomic Nervous System; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrophysiology; Heart; Heart Failure; Humans; Quality of Life; Risk Assessment; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed, Single-Photon | 2015 |
Chemistry and biology of radiotracers that target changes in sympathetic and parasympathetic nervous systems in heart disease.
Topics: 3-Iodobenzylguanidine; Ephedrine; Heart; Heart Diseases; Heart Failure; Humans; Ligands; Norepinephrine; Parasympathetic Nervous System; Protein Binding; Radionuclide Imaging; Sympathetic Nervous System | 2015 |
¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study.
Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Female; Follow-Up Studies; Heart Failure; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Risk Factors; ROC Curve; Time Factors; Ventricular Function, Left | 2015 |
Preoperative iodine-123 meta-iodobenzylguanidine imaging is a novel predictor of left ventricular reverse remodeling during treatment with a left ventricular assist device.
Topics: 3-Iodobenzylguanidine; Adult; Aortic Valve; Cardiomyopathy, Dilated; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Prognosis; Ventricular Remodeling; Young Adult | 2016 |
First determination of the heart-to-mediastinum ratio using cardiac dual isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Gamma Cameras; Heart; Heart Failure; Humans; Male; Mediastinum; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Phantoms, Imaging; Tomography, Emission-Computed, Single-Photon | 2015 |
The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Consensus; Death, Sudden, Cardiac; Defibrillators, Implantable; Disease Management; Heart; Heart Failure; Heart-Assist Devices; Humans; Iodine Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2015 |
The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Drug Administration Schedule; Female; Heart; Heart Failure; Humans; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed, Single-Photon | 2016 |
The time has come to standardize (123)I-MIBG heart-to-mediastinum ratios including planar and SPECT methods.
Topics: 3-Iodobenzylguanidine; Female; Gamma Cameras; Heart; Heart Failure; Humans; Male; Mediastinum; Organophosphorus Compounds; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 2016 |
Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
Topics: 3-Iodobenzylguanidine; Aged; Chi-Square Distribution; Decision Support Techniques; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Europe; Female; Heart Failure; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Nonlinear Dynamics; North America; Patient Selection; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Decision Making for Implantable Cardioverter Defibrillator Implantation: Is There a Role for Neurohumoral Imaging?
Topics: 3-Iodobenzylguanidine; Decision Support Techniques; Defibrillators, Implantable; Electric Countershock; Female; Heart Failure; Humans; Male; Radiopharmaceuticals; Systole; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models.
Topics: 3-Iodobenzylguanidine; Aged; Cause of Death; Chronic Disease; Cohort Studies; Databases, Factual; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Time Factors | 2016 |
Impact of renal sympathetic denervation on cardiac sympathetic nerve activity evaluated by cardiac MIBG imaging.
Topics: 3-Iodobenzylguanidine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Disease Progression; Drug Resistance; Echocardiography; Female; Heart; Heart Failure; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Renal Artery; Risk Factors; Sympathectomy; Sympathetic Nervous System; Treatment Outcome | 2016 |
Assessment of
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Causality; Comorbidity; Female; Heart Failure; Humans; Incidence; Internationality; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Survival Rate | 2017 |
(123)I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Resynchronization Therapy; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Treatment Outcome | 2016 |
Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cause of Death; Cost-Benefit Analysis; Decision Support Techniques; Defibrillators, Implantable; Female; Heart Failure; Humans; Life Tables; Male; Middle Aged; Quality-Adjusted Life Years; Radiopharmaceuticals; Risk Assessment; United States | 2016 |
Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-1 Receptor Agonists; Aged; Blood Pressure; Exercise Test; Female; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Nebivolol; Oxygen Consumption; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Vasodilator Agents | 2016 |
Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure.
Topics: 3-Iodobenzylguanidine; End Stage Liver Disease; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Time Factors; Ventricular Function, Left | 2016 |
Impact of aging on cardiac sympathetic innervation measured by
Topics: 3-Iodobenzylguanidine; Aged; Aging; Cardiac Imaging Techniques; Female; Heart Failure; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2016 |
Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Calcium Channel Blockers; Drug Interactions; Heart; Heart Failure; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Myocardium; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathomimetics | 2017 |
I-123 metaiodobenzylguanidine innervation imaging as a tool for norepinephrine transporter research: A possible application for genetic analysis in heart failure.
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Iodine Radioisotopes; Norepinephrine Plasma Membrane Transport Proteins; Radionuclide Imaging | 2018 |
Does inflammation get on nerves in patients with heart failure?
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Inflammation; Iodine Radioisotopes; Myocardial Perfusion Imaging | 2018 |
Imaging of cardiac sympathetic activity in heart failure: Not out of the woods yet.
Topics: 3-Iodobenzylguanidine; Exercise; Heart Failure; Humans; Iodine Radioisotopes; Radionuclide Imaging | 2018 |
Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Output, Low; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2018 |
Reduced lung uptake of iodine-123 metaiodobenzylguanidine in high-altitude pulmonary oedema.
Topics: 3-Iodobenzylguanidine; Adult; Altitude; Endothelium, Vascular; Female; Heart Failure; Humans; Lung; Male; Middle Aged; Pulmonary Edema; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Study of the adrenergic heart innervation with iodine 123-metaiodobenzylguanidine in heart failure before transplantation.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Biological Transport; Child; Female; Heart; Heart Failure; Heart Transplantation; Humans; Middle Aged; Premedication; Prognosis; Tomography, Emission-Computed; Young Adult | 2008 |
Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.
Topics: 3-Iodobenzylguanidine; Adult; Artifacts; Female; Heart; Heart Failure; Humans; Hypertension; Liver; Lung; Male; Mediastinum; Middle Aged; Multivariate Analysis; Myocardium; Radionuclide Imaging; Time Factors | 2009 |
123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Prognosis; Radionuclide Imaging | 2009 |
Clinical significance of iodine-123 metaiodobenzylguanidine cardiac imaging.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart Failure; Humans; Iodine Radioisotopes; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index | 2009 |
Improvement in a patient suffering from cardiac injury due to severe hydrogen sulfide poisoning: a long-term examination of the process of recovery of heart failure by performing nuclear medicine study.
Topics: 3-Iodobenzylguanidine; Adult; Echocardiography; Electrocardiography; Fatty Acids; Heart Failure; Humans; Hydrogen Sulfide; Iodobenzenes; Male; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Suicide, Attempted; Time Factors | 2009 |
Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Fibrillation; C-Reactive Protein; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Iodine Radioisotopes; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk; Stroke; Sympathetic Nervous System | 2010 |
Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Cause of Death; Disease-Free Survival; Exercise Test; Female; Heart; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Patient Selection; Prospective Studies; Radionuclide Imaging; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2010 |
Myocardial sympathetic innervation and long-term left ventricular mechanical unloading.
Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Creatinine; Female; Follow-Up Studies; Heart; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Pulmonary Wedge Pressure; Radiopharmaceuticals; Recovery of Function; Sodium; Stroke Volume; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Ventricular Function, Left; Young Adult | 2010 |
Adrenergic excess, hNET1 down-regulation, and compromised mIBG uptake in heart failure poverty in the presence of plenty.
Topics: 3-Iodobenzylguanidine; Down-Regulation; Epinephrine; Heart; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Myocardium; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Up-Regulation; Ventricular Function, Left | 2010 |
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Research Design; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2010 |
I-123 MIBG cardiac uptake measurements: limitations of collimator choice and scatter correction in the clinical context.
Topics: 3-Iodobenzylguanidine; Artifacts; Biological Transport; Female; Heart Failure; Humans; Injections; Male; Mediastinum; Middle Aged; Myocardium; Radiation Dosage; Radionuclide Imaging; Scattering, Radiation | 2010 |
Metaiodobenzylguanidine imaging comes of age. A new arrow in the prognostic quiver for heart failure patients.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Mediastinum; Myocardium; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2010 |
Norepinephrine spillover during exercise as a novel parameter to evaluate the severity of heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals | 2010 |
Washout rate of cardiac iodine-123 metaiodobenzylguanidine is high in chronic heart failure patients with central sleep apnea.
Topics: 3-Iodobenzylguanidine; Aged; Female; Health Status Indicators; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Polysomnography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Sleep Apnea, Central; Statistics, Nonparametric; Stroke Volume; Sympathetic Nervous System; Ventricular Function, Left | 2010 |
Long-term prognostic value of analysis of sympathetic drive by myocardial 123I-metaiodobenzylganidine scintigraphy in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aprotinin; Brain; Echocardiography; Edetic Acid; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Natriuretic Peptides; Prognosis; Prospective Studies | 2010 |
New opportunities and challenges for clinical application of mIBG imaging.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Heart Failure; Heart Rate; Humans; Iodine Radioisotopes; Prognosis; Radiopharmaceuticals | 2010 |
Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Body Mass Index; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiomyopathies; Creatine; Diagnosis, Differential; Fatty Acids; Female; Heart Failure; Humans; Iodobenzenes; Male; Middle Aged; Myocardium; Nuclear Magnetic Resonance, Biomolecular; Radiopharmaceuticals; Severity of Illness Index; Statistics as Topic; Sympathetic Nervous System; Tissue Distribution; Triglycerides; Ventricular Function, Left | 2010 |
Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients.
Topics: 3-Iodobenzylguanidine; Aged; Chi-Square Distribution; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2011 |
Iodine-123 mIBG Imaging for Predicting the Development of Atrial Fibrillation.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Fibrillation; Electrocardiography; Female; Heart; Heart Failure; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2011 |
Does cardiac sympathetic innervation imaging fulfill an unmet need for managing atrial fibrillation?
Topics: 3-Iodobenzylguanidine; Atrial Fibrillation; Heart; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Stroke Volume; Sympathetic Nervous System | 2011 |
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Iodine Radioisotopes; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Severity of Illness Index; Survival Rate; Washington | 2011 |
Cardiac autonomic denervation in diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Heart; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2011 |
Relationship between cardiac adrenergic image and exercise testing in heart failure.
Topics: 3-Iodobenzylguanidine; Blood Pressure; Exercise Test; Exercise Tolerance; Female; Heart; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Statistics, Nonparametric | 2011 |
An independent prognostic factor for heart failure: sympathetic hyperactivity.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Natriuretic Peptides; Prognosis; Prospective Studies | 2011 |
MIBG and risk stratification.
Topics: 3-Iodobenzylguanidine; Defibrillators, Implantable; Heart Failure; Humans; Radiopharmaceuticals; Risk Assessment | 2011 |
Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
Topics: 3-Iodobenzylguanidine; Aged; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Iodine Radioisotopes; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Proportional Hazards Models; Radionuclide Imaging; Sensitivity and Specificity; Stroke | 2012 |
A step forward in the use of SPECT imaging with I-123 MIBG.
Topics: 3-Iodobenzylguanidine; Female; Heart; Heart Failure; Humans; Male; Myocardium; Tomography, Emission-Computed, Single-Photon | 2012 |
Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.
Topics: 3-Iodobenzylguanidine; Action Potentials; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Sudden; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Risk | 2012 |
Is abnormal adrenergic activation associated with abnormal Heart Rate Recovery?
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Exercise Test; Female; Heart; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Statistics, Nonparametric; Time Factors | 2012 |
Interobserver variability of heart-to-mediastinum ratio in I-123 MIBG sympathetic imaging.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Female; Heart Failure; Humans; Male; Myocardial Perfusion Imaging; Prognosis; Radiopharmaceuticals; Reproducibility of Results | 2012 |
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Prosthesis Implantation; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon | 2012 |
A key role for nuclear cardiac imaging in evaluating and managing patients with heart failure.
Topics: 3-Iodobenzylguanidine; Female; Heart Failure; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Area Under Curve; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Risk | 2012 |
Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Disease Progression; Female; Heart; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; United States; Ventricular Function, Left | 2012 |
Quantitative 123I-MIBG SPECT/CT assessment of cardiac sympathetic innervation--a new diagnostic tool for heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Sympathetic Fibers, Postganglionic | 2013 |
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Heart; Heart Failure; Humans; Interleukin-1; Interleukin-6; Male; Middle Aged; Oxygen Consumption; Radiopharmaceuticals; Receptors, Tumor Necrosis Factor; Regression Analysis; Sympathetic Nervous System; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2003 |
Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Heart; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Sympatholytics; Ventricular Dysfunction | 2003 |
Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Aged; Blood Pressure; Chemokine CXCL9; Chemokines, CXC; Echocardiography; Female; Heart; Heart Failure; Humans; Intercellular Signaling Peptides and Proteins; Male; Mediastinum; Middle Aged; Myocardium; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Time Factors | 2003 |
[Clinical usefulness of a dual L/N-type Ca2+ channel blocker, cilnidipine, in patients with chronic heart failure: assessment with 123I-MIBG myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Calcium Channel Blockers; Dihydropyridines; Female; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Diabetes Mellitus; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume | 2004 |
Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence.
Topics: 3-Iodobenzylguanidine; Clinical Trials as Topic; Evidence-Based Medicine; Heart Failure; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Cardiac sympathetic nerve activity can detect congestive heart failure sensitively in patients with hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Volume; Cardiomyopathies; Early Diagnosis; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2004 |
Cardiac resynchronization induces favorable neurohumoral changes.
Topics: 3-Iodobenzylguanidine; Cardiac Pacing, Artificial; Echocardiography, Doppler; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Ischemia; Myocardium; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric | 2005 |
Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium.
Topics: 3-Iodobenzylguanidine; Autopsy; Fatal Outcome; Female; Heart Failure; Heart Ventricles; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2005 |
The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Diastole; Echocardiography, Doppler, Pulsed; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Heart Failure; Humans; Male; Myocardial Contraction; Prognosis; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2006 |
123I- Metaiodobenzylguanidine in chronic heart failure: Is there a clinical use?
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Metabolic Clearance Rate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2006 |
Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2007 |
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Disease-Free Survival; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Male; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2007 |
Monitoring of therapeutic effect in heart failure patients: a clinical application of 123I MIBG imaging?
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Relationship between plasma norepinephrine at peak exercise and 123I-MIBG imaging of the heart and lower limbs in heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Biomarkers; Exercise; Exercise Test; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Lower Extremity; Male; Middle Aged; Nerve Endings; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System | 2007 |
Significant improvement of cardiac sympathetic function following cardiac support device implantation: illustration by 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Heart-Assist Devices; Humans; Iodine Radioisotopes; Male; Middle Aged; Postoperative Period; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2007 |
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Carbon Radioisotopes; Cardiomyopathies; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Presynaptic Terminals; Propanolamines; Radiopharmaceuticals; Receptors, Adrenergic, beta; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2007 |
Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Follow-Up Studies; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2007 |
[Basal tako-tsubo cardiomyopathy. Induction of a pheochromocytoma after general anesthesia].
Topics: 3-Iodobenzylguanidine; Aged; Anesthesia, General; Cataract Extraction; Electrocardiography; Female; Heart Failure; Humans; Pheochromocytoma; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Ultrasonography; Ventricular Dysfunction, Left | 2008 |
I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
Topics: 3-Iodobenzylguanidine; Coronary Artery Disease; Heart; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Ventricular Dysfunction, Left | 2008 |
Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Comorbidity; Female; Heart Failure; Humans; Incidence; Japan; Male; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Survival Analysis; Survival Rate; Ventricular Dysfunction, Left | 2008 |
Re: Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy.
Topics: 3-Iodobenzylguanidine; Cardiac Pacing, Artificial; Heart; Heart Failure; Humans; Iodine Radioisotopes; Medical Errors; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2008 |
Assessment of adrenergic neuron function altered with progression of heart failure.
Topics: 3-Iodobenzylguanidine; Animals; Antibiotics, Antineoplastic; Autoradiography; Doxorubicin; Heart; Heart Failure; Iodine Radioisotopes; Iodobenzenes; Male; Myocardium; Neurons; Norepinephrine; Radionuclide Angiography; Rats; Rats, Wistar; Sympathetic Nervous System; Sympatholytics; Tritium | 1995 |
Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Liver; Male; Mediastinum; Middle Aged; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System; Ventricular Function, Left | 1995 |
[What are the criteria of priority for the patient to be accepted on the waiting list for cardiac transplantation?].
Topics: 3-Iodobenzylguanidine; Adult; Female; France; Heart; Heart Failure; Heart Transplantation; Humans; Iodobenzenes; Male; Middle Aged; Patient Selection; Prognosis; Prospective Studies; Radionuclide Imaging; Sympatholytics; Time Factors; Waiting Lists | 1995 |
[Serial assessment of MIBG scintigraphy in a case of DCM with heart failure improved by beta-blocker therapy].
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Metoprolol; Middle Aged; Monitoring, Physiologic; Radionuclide Imaging | 1995 |
Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Heart Transplantation; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Myocardium; Nerve Regeneration; Norepinephrine; Radionuclide Imaging; Rheumatic Heart Disease; Sympathetic Nervous System | 1995 |
[Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Observer Variation; Predictive Value of Tests; Tomography, Emission-Computed, Single-Photon | 1994 |
Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Animals; Cardiac Pacing, Artificial; Dogs; Heart; Heart Failure; Iodine Radioisotopes; Iodobenzenes; Myocardium; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System | 1994 |
A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure.
Topics: 3-Iodobenzylguanidine; Clonidine; Female; Heart; Heart Failure; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Image Processing, Computer-Assisted; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Premedication; Radionuclide Imaging; Reproducibility of Results; Sympatholytics | 1993 |
Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference.
Topics: 3-Iodobenzylguanidine; Evaluation Studies as Topic; Female; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Observer Variation; Phantoms, Imaging; Reproducibility of Results; Sympatholytics; Tomography, Emission-Computed, Single-Photon | 1995 |
Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardium; Norepinephrine; Radionuclide Imaging; Regression Analysis; Thallium Radioisotopes; Tissue Distribution | 1996 |
Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload.
Topics: 3-Iodobenzylguanidine; Atrial Natriuretic Factor; Cardiac Catheterization; Cardiac Output; Case-Control Studies; Contrast Media; Echocardiography, Doppler; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Stenosis; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System; Time Factors; Ventricular Function, Left; Ventricular Pressure | 1996 |
Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
Topics: 3-Iodobenzylguanidine; Animals; Down-Regulation; Heart; Heart Failure; Heart Ventricles; Iodobenzenes; Male; Norepinephrine; Rabbits; Receptors, Adrenergic, beta; Sympathetic Nervous System; Sympatholytics; Ventricular Dysfunction, Left | 1996 |
Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardium; Norepinephrine; Prospective Studies; Sympatholytics; Tomography, Emission-Computed, Single-Photon | 1996 |
Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies.
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Cardiomyopathies; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardium; Predictive Value of Tests; Prognosis; Regression Analysis; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1996 |
Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Cardiac Output, Low; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1996 |
[Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Aged; Contrast Media; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Stenosis; Radionuclide Imaging; Sympathetic Nervous System | 1997 |
ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardium; Radionuclide Imaging | 1997 |
Comparison between iodine 123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Heart; Heart Failure; Heart Rate; Humans; Middle Aged; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 1997 |
[The results of questionnaire on quantitative assessment of 123I-metaiodobenzylguanidine myocardial scintigraphy in heart failure].
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, Emission-Computed, Single-Photon | 1997 |
[Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathy, Dilated; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Ischemia; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes | 1998 |
[Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Digoxin; Diuretics; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Function, Left | 1998 |
Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dilated; Echocardiography; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Neurons; Norepinephrine; Oxygen Consumption; Radionuclide Angiography; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System | 1999 |
Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Oxygen Consumption; Prognosis; Prospective Studies; Radionuclide Ventriculography; Radiopharmaceuticals; ROC Curve; Severity of Illness Index | 1999 |
Clues to prognosis in congestive heart failure.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Heart Failure; Humans; Iodine Radioisotopes; Oxygen Consumption; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Ventricular Function, Left | 1999 |
Heterogeneous cardiac sympathetic innervation in heart failure after myocardial infarction of rats.
Topics: 3-Iodobenzylguanidine; Animals; Blood Pressure; Chronic Disease; Heart; Heart Failure; Iodine Radioisotopes; Iodocyanopindolol; Male; Myocardial Infarction; Myocardium; Norepinephrine; Organ Size; Radionuclide Imaging; Rats; Rats, Wistar; Receptors, Adrenergic; Sympathetic Nervous System; Tissue Distribution; Ventricular Remodeling | 2000 |
[Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Biomarkers; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Subtraction Technique | 2000 |
Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic Fibers; Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cardiomyopathies; Fatty Acids; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Muscle Fibers, Skeletal; Myocardium; Organometallic Compounds; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
[Assessment of cardiac sympathetic nerve activity in children with chronic heart failure using quantitative iodine-123 metaiodobenzylguanidine imaging].
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Chronic Disease; Female; Heart; Heart Failure; Humans; Infant; Male; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System | 2000 |
Serious arrhythmias in patients with apical hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Defibrillators, Implantable; Electrocardiography; Female; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Fibrillation | 2001 |
Studying the neuronal side of the synaptic cleft. A tool for investigating the paradox of sympathetic nervous system and heart failure in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Animals; Cardiomyopathy, Dilated; Catecholamines; Ephedrine; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic; Sympathetic Nervous System; Synaptic Transmission | 2001 |
Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support.
Topics: 3-Iodobenzylguanidine; Adult; Atrial Natriuretic Factor; Cardiomyopathies; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2001 |
Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Ventricular Dysfunction, Left | 2001 |
Relationship between cardiac metaiodobenzylguanidine uptake and hemodynamic, functional and neurohormonal parameters in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Disease Progression; Exercise Test; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume | 2001 |
Relationship between cardiac 123I-metaiodobenzylguanidine imaging and the transcardiac gradient of neurohumoral factors in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Biological Transport, Active; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments--comparison with neurohumoral factors.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Time Factors; Ventricular Function, Left | 2002 |
Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Iodobenzenes; Male; Middle Aged; Myocardial Contraction; Neurons; Norepinephrine; Radionuclide Imaging; Receptors, Adrenergic, beta | 1992 |
Prognosis in congestive heart failure: what information can best predict the future?
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Prognosis; Radionuclide Imaging | 1992 |
Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Echocardiography; Female; Follow-Up Studies; France; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multivariate Analysis; Prognosis; Radionuclide Imaging; Stroke Volume; Survival Rate; Ventricular Function, Left | 1992 |
Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Animals; Body Weight; Dose-Response Relationship, Drug; Doxorubicin; Heart; Heart Failure; Heart Ventricles; Iodine Radioisotopes; Iodobenzenes; Male; Myocardium; Norepinephrine; Rats; Rats, Inbred Strains; Thallium Radioisotopes | 1992 |
Adriamycin, congestive cardiomyopathy, and metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Dose-Response Relationship, Drug; Doxorubicin; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Radionuclide Imaging; Ventricular Function, Left | 1992 |
[Clinical significance of I-123 MIBG myocardial scintigraphy for evaluating the severity of congestive heart failure].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging | 1991 |